Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam with or without propofol for painless bronchoscopy in elderly patients
ChiCTR2300071137Phase 4Not yet recruiting
- Sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol in bronchopulmonary diseases (3 arms), sponsored by The Fourth Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoints: SpO2 and respiratory rate. Planned start May 2023; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
bronchopulmonary diseases
Beyond the preview
Go deeper on ChiCTR2300071137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071137.